{
    "clinical_study": {
        "@rank": "90815", 
        "arm_group": [
            {
                "arm_group_label": "Insulin, Travasol (35%) postop", 
                "arm_group_type": "Experimental", 
                "description": "Insulin (hyperinsulinemic-normoglycemic clamp) with Travasol (amino acid supplementation) given from start of surgery to 6 hours after, at an amount of 35% of patient's energy expenditure as measured before surgery, ."
            }, 
            {
                "arm_group_label": "Insulin, Travasol (20%) postop", 
                "arm_group_type": "Experimental", 
                "description": "Insulin (hyperinsulinemic-normoglycemic clamp) with Travasol (amino acid infusion), given from start of surgery to 6 hours after, at an amount of 20% of patient's energy expenditure as measured before surgery."
            }, 
            {
                "arm_group_label": "Insulin, no protein after surgery", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Insulin (hyperinsulinemic-normoglycemic clamp, an insulin infusion between 2 and 5 microunits/kg with glucose at a variable rated titrated to maintain normoglycemia, blood glucose 4-6 mmol/L) with no protein supplementation from start of surgery to 6 hours after."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to find out whether adding insulin after current colorectal\n      cancer surgery promotes making and keeping proteins in the body, and to find out whether or\n      not this effect can be further increased by increasing the amount of protein given."
        }, 
        "brief_title": "Enhancing the Anabolic Effect of Perioperative Nutrition With Insulin While Maintaining Normoglycemia", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Colorectal Cancer", 
        "condition_browse": {
            "mesh_term": "Colorectal Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  American Society of Anesthesiologists class<3\n\n          -  age>18 years\n\n          -  colorectal surgery for non-metastatic colorectal adenocarcinoma including right and\n             left hemicolectomy, transverse, subtotal and total colectomy sigmoid and low anterior\n             resection\n\n          -  ability to give informed consent\n\n        Exclusion Criteria:\n\n          -  BMI>30 Kg/meter squared\n\n          -  confirmed diagnosis of diabetes mellitus or a HbA1c>6.0%\n\n          -  significant cardiorespiratory, hepatic, renal and neurological disease\n\n          -  musculoskeletal or neuromuscular disease\n\n          -  ingestion of drugs known to affect protein, glucose and lipid metabolism (e.g.\n             steroids)\n\n          -  severe anemia (hemoglobin<10 g/dL\n\n          -  pregnancy\n\n          -  history of severe sciatica, back surgery or other conditions which contraindicate the\n             use of epidural catheters"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "24", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 8, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02032953", 
            "org_study_id": "12-459-GEN"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Insulin, Travasol (35%) postop", 
                    "Insulin, Travasol (20%) postop"
                ], 
                "description": "an amino acid supplementation infused intravenously containing essential and non-essential amino acids", 
                "intervention_name": "Travasol (amino acid injection)", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "Travasol"
            }, 
            {
                "arm_group_label": [
                    "Insulin, Travasol (35%) postop", 
                    "Insulin, Travasol (20%) postop", 
                    "Insulin, no protein after surgery"
                ], 
                "description": "After the insertion of an arterial catheter and obtainin a baseline arterial blood glucose value, 2 units of insluin will be administered iv followed by an infusion of 2 microunits/kg*min. Ten minuts after starting the insulin, and when the the blood glucose is<6 mmol/L, dextrose 20% supplemented with phosphate  (30mmol/L) will be infused. Blood gluxose levels measured every 15 minuts and the destrose infusion rate adjusted to maintain arterial glycemia between 4 and 6 mmol/L until end of study.", 
                "intervention_name": "Insulin", 
                "intervention_type": "Drug", 
                "other_name": [
                    "HNC", 
                    "Hyperinsulinemic-normoglycemic clamp"
                ]
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Insulin", 
                "Anabolic Agents"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "colorectal cancer", 
            "protein recovery", 
            "perioperative nutrition", 
            "hyperinsulinemia", 
            "normoglycemia", 
            "hyperinsulinemic-normoglycemic clamp", 
            "anabolism"
        ], 
        "lastchanged_date": "January 9, 2014", 
        "location": {
            "contact": {
                "email": "thomas.schricker@mcgill.ca", 
                "last_name": "Thomas Schricker, MD", 
                "phone": "514-934-1934", 
                "phone_ext": "34884"
            }, 
            "facility": {
                "address": {
                    "city": "Montreal", 
                    "country": "Canada", 
                    "state": "Quebec", 
                    "zip": "H8A1A1"
                }, 
                "name": "McGill University Health Centre (MUHC) - Royal Victoria Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Thomas Shricker, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Ralph Lattermann, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Sarkis Meterissian, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Linda Wykes, PhD.", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "3", 
        "official_title": "Enhancing the Anabolic Effect of Perioperative Nutrition With Insulin While Maintaining Normoglycemia", 
        "overall_contact": {
            "email": "thomas.schricker@mcgill.ca", 
            "last_name": "Thomas Schricker, MD", 
            "phone": "514-934-1934", 
            "phone_ext": "34884"
        }, 
        "overall_official": {
            "affiliation": "McGill University Health Center", 
            "last_name": "Thomas Schricker, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Health Canada", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The difference in total body protein after randomization to one of the three treatment arms.", 
            "measure": "Net protein balance", 
            "safety_issue": "No", 
            "time_frame": "6 hours after surgery"
        }, 
        "reference": {
            "PMID": "15492576", 
            "citation": "Schricker T, Meterissian S, Wykes L, Eberhart L, Lattermann R, Carli F. Postoperative protein sparing with epidural analgesia and hypocaloric dextrose. Ann Surg. 2004 Nov;240(5):916-21."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02032953"
        }, 
        "responsible_party": {
            "investigator_affiliation": "McGill University Health Center", 
            "investigator_full_name": "Thomas Schricker", 
            "investigator_title": "Chief of Anesthesia", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "results_reference": {
            "PMID": "10950834", 
            "citation": "Schricker T, Wykes L, Carli F. Epidural blockade improves substrate utilization after surgery. Am J Physiol Endocrinol Metab. 2000 Sep;279(3):E646-53."
        }, 
        "source": "McGill University Health Center", 
        "sponsors": {
            "collaborator": {
                "agency": "Canadian Institutes of Health Research  (CIHR)", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "McGill University Health Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}